Ipsen (IPSEY) ROE % Adjusted to Book Value : 2.49% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ipsen ROE % Adjusted to Book Value?

Ipsen's ROE % for the quarter that ended in Dec. 2024 was 5.46%. Ipsen's PB Ratio for the quarter that ended in Dec. 2024 was 2.19. Ipsen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 2.49%.

Ipsen ROE % Adjusted to Book Value Historical Data

The historical data trend for Ipsen's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen ROE % Adjusted to Book Value Chart

Ipsen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

11.34

10.24

8.25

7.79

3.87

Ipsen Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															6.33	4.25	10.65	5.09	2.49

Competitive Comparison of Ipsen's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ipsen's ROE % Adjusted to Book Value falls into.

Ipsen ROE % Adjusted to Book Value Calculation

Ipsen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	8.47%	/	2.19
	=	3.87%

Ipsen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.46%	/	2.19
	=	2.49%

Ipsen ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ipsen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEY) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

IPSEF:USA IPNp:UK 0MH6:UK IPN:France I7G:Germany IPN:Austria

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.